Next Life Sciences
PrivateLast Round
Series A
Apr 3, 2025
Total Funding Raised
$4.05M
Momentum Score
25 /100
Company Overview
Next Life Sciences, Inc. is a public-benefit corporation developing "Plan A," a non-hormonal, on-demand male contraceptive. The product is a hydrogel that is injected into the vas deferens to temporarily block sperm flow, designed to be a long-lasting and reversible contraceptive controlled by the user. The company is a spin-out from the Los Angeles BioMedical Research Institute (now The Lundquist Institute) and is supported by the National Institutes of Health (NIH) and the Male Contraceptive Initiative (MCI). As of late 2025, the company is in the preclinical stage of development.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Next Life Sciences Comps
Public and private peers based on sector, stage, and business model.
Next Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 3, 2025 | ||||
| Seed | Jan 18, 2024 | ||||
| Seed | Jun 5, 2023 |
Next Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Joy Fund | Seed |
| The Pay It Forward Company | Seed |
| Particular Ventures | Seed |
| Transform VC | Seed |
| Unpopular Ventures | Seed |
| StartUp Health | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
FDA regulatory expert Peter Barton Hutt joins advisory board.
Next Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Next Life Sciences's valuation, stock price, and market status.
